Global Biologics Development and Manufacturing Testing Market

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Biologics Development and Manufacturing Testing Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Biologics Development and Manufacturing Testing Market by Test Technology: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  In Vivo Safety Testing

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  In Vitro Safety Testing

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Safety Testing Analytical Services

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Biologics Development and Manufacturing Testing Market by Geography: Market Size and Forecast, 2019 - 2028 

5.1  Overview

5.1.1   Global Biologics Development Market Year-on-Year Growth, by region 2020 – 2028 (%)

5.2  North America

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   U.S.

5.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3.2        By Test Technology

5.2.4   Canada

5.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.4.2        By Test Technology

5.2.5   Mexico

5.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.5.2        By Test Technology

5.3    Europe

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   UK

5.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3.2        By Test Technology

5.3.4   Russia

5.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.4.2        By Test Technology

5.3.5   France

5.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.5.2        By Test Technology

5.3.6   Italy

5.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.6.2        By Test Technology

5.3.7   Germany

5.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.7.2        By Test Technology

5.3.8   Rest of Europe

5.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.8.2        By Test Technology

5.4    Asia-Pacific

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3   China

5.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3.2        By Test Technology

5.4.4   India

5.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.4.2        By Test Technology

5.4.5   Japan

5.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.5.2        By Test Technology

5.4.6   Rest of Asia-Pacific

5.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.6.2        By Test Technology

5.5    RoW

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast

5.5.3   South America

5.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3.2        By Test Technology

5.5.4   Middle East

5.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.4.2        By Test Technology

5.5.5   Africa

5.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.5.2        By Test Technology

Chapter 6        Company Profiles

6.1  Admecell Inc.

6.1.1     Company Overview

6.1.2     Product Portfolio

6.1.3     Business Strategies

6.1.4     Financials

6.1.5     Recent Developments

6.2  American Type Culture Collection(ATCC)

6.2.1     Company Overview

6.2.2     Product Portfolio

6.2.3     Business Strategies

6.2.4     Financials

6.2.5     Recent Developments

6.3  Avance Biosciences

6.3.1     Company Overview

6.3.2     Product Portfolio

6.3.3     Business Strategies

6.3.4     Financials

6.3.5     Recent Developments

6.4  Bioreliance

6.4.1     Company Overview

6.4.2     Product Portfolio

6.4.3     Business Strategies

6.4.4     Financials

6.4.5     Recent Developments

6.5  BSL Bioservice

6.5.1     Company Overview

6.5.2     Product Portfolio

6.5.3     Business Strategies

6.5.4     Financials

6.5.5     Recent Developments

6.6  Catalent Inc.

6.6.1     Company Overview

6.6.2     Product Portfolio

6.6.3     Business Strategies

6.6.4     Financials

6.6.5     Recent Developments

6.7  Charles River Laboratories

6.7.1     Company Overview

6.7.2     Product Portfolio

6.7.3     Business Strategies

6.7.4     Financials

6.7.5     Recent Developments

6.8  Covance

6.8.1     Company Overview

6.8.2     Product Portfolio

6.8.3     Business Strategies

6.8.4     Financials

6.8.5     Recent Developments

6.9  Cytovance Biologics

6.9.1     Company Overview

6.9.2     Product Portfolio

6.9.3     Business Strategies

6.9.4     Financials

6.9.5     Recent Developments

6.10       EMD Millipore

6.10.1   Company Overview

6.10.2   Product Portfolio

6.10.3   Business Strategies

6.10.4   Financials

6.10.5   Recent Developments

6.11       Eurofins Scientific

6.11.1   Company Overview

6.11.2   Product Portfolio

6.11.3   Business Strategies

6.11.4   Financials

6.11.5   Recent Developments

6.12       Intertek Group Plc

6.12.1   Company Overview

6.12.2   Product Portfolio

6.12.3   Business Strategies

6.12.4   Financials

6.12.5   Recent Developments

6.13       Lonza Group

6.13.1   Company Overview

6.13.2   Product Portfolio

6.13.3   Business Strategies

6.13.4   Financials

6.13.5   Recent Developments

6.14       Pharmaceutical Product Development LLC(PPD)

6.14.1   Company Overview

6.14.2   Product Portfolio

6.14.3   Business Strategies

6.14.4   Financials

6.14.5   Recent Developments

6.15       Sartorius AG

6.15.1   Company Overview

6.15.2   Product Portfolio

6.15.3   Business Strategies

6.15.4   Financials

6.15.5   Recent Developments

6.16       Sekisui Xenotech Llc

6.16.1   Company Overview

6.16.2   Product Portfolio

6.16.3   Business Strategies

6.16.4   Financials

6.16.5   Recent Developments

6.17       Selexis SA

6.17.1   Company Overview

6.17.2   Product Portfolio

6.17.3   Business Strategies

6.17.4   Financials

6.17.5   Recent Developments

6.18       SGS S.A Corp.

6.18.1   Company Overview

6.18.2   Product Portfolio

6.18.3   Business Strategies

6.18.4   Financials

6.18.5   Recent Developments

6.19       Sigma – Aldrich

6.19.1   Company Overview

6.19.2   Product Portfolio

6.19.3   Business Strategies

6.19.4   Financials

6.19.5   Recent Developments

6.20       Toxikon Corp.

6.20.1   Company Overview

6.20.2   Product Portfolio

6.20.3   Business Strategies

6.20.4   Financials

6.20.5   Recent Developments